#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adult T-cell lymphoma/leukaemia refractory Fungal infection Autoimmune disorder Haemophagocytic lymphohistiocytosis Non-Hodgkin's lymphoma unspecified histology indolent Cutaneous T-cell lymphoma refractory Pancreatic carcinoma metastatic Microvillous inclusion disease Advanced systemic mastocytosis Metachromatic leukodystrophy Asthma Desmoplastic small round cell tumour Hereditary neuropathic amyloidosis Ovarian cancer stage III Cardiac arrest More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Treatment Friedreich’s ataxia – Trials in Disease Leiomyosarcoma recurrent – Life with Disease Inclusion body myositis – Basic Information Bronchiolitis obliterans syndrome Mucopolysaccharidosis II – Treatment Lennox-Gastaut syndrome – Basic Information Ewing’s sarcoma recurrent – Treatment Sjogren’s syndrome – Diagnostics Lymphangiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taxanes Bgb-A445 Cefoxitin Afm24 Deucravacitinib VERTEPORFIN XYLOMETAZOLINE HYDROCHLORIDE Esketamine Hydrochloride Pyridoxine Hydrochloride 177Lu-Dpi-4452 Sodium Fluoride (18F) Phenylbutyrate Glenzocimab CHLORMADINONE ACETATE Ads-015 Rifampicin Mavacamten Cenegermin AP31969 SULFATE Odm-208 More therapies…

    Learn about Your Condition

    Hepatic fibrosis Aortic aneurysm Stress Decreased appetite Perthes disease External cephalic version Retinal neovascularisation Haemorrhage prophylaxis KBG syndrome Asthma Hyperchylomicronaemia Cerebrovascular accident Parkinson's disease Hypersomnia Chronic coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study on the Effectiveness and Safety of Silibinin for Patients with Active Cushing’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Silibinin
    Italy

  • Study on Semaglutide and Low-Calorie Diet for Weight Loss in Patients with New-Onset Idiopathic Intracranial Hypertension

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Idiopathic intracranial hypertension
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on Testosterone Therapy for Men with Low Testosterone and Prostate Cancer Undergoing Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypogonadism male
    Investigated Drugs:
    • Testosterone
    The Netherlands

  • Study on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Paltusotine
    Germany Greece Hungary

  • Study on the Safety and Effectiveness of TransCon PTH for Adults with Hypoparathyroidism

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Palopegteriparatide
    Denmark Germany Italy Norway

  • Study on Hydrocortisone and Placebo for Patients with Giant Cell Arteritis or Polymyalgia Rheumatica Experiencing Adrenal Insufficiency Symptoms

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Tertiary adrenal insufficiency
    Investigated Drugs:
    • Placebo
    • Hydrocortisone
    Denmark
Previous Page
1 … 14 15 16 17 18 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!